Abstract: Described herein are compositions and methods for treating cancers, such as characterized by chronic inflammation or expression of GM1 ganglioside receptors
Type:
Application
Filed:
September 3, 2018
Publication date:
March 25, 2021
Applicant:
Valneva Sweden AB
Inventors:
Klaus Schwamborn, Tim Wood, Jianguang Ji, Jan Sundquist, Kristina Sundquist